Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Free Report) – Investment analysts at HC Wainwright boosted their FY2025 EPS estimates for shares of Dianthus Therapeutics in a research note issued to investors on Monday, November 10th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($3.18) per share for the year, up from their [...]
HC Wainwright Has Strong Forecast for DNTH FY2025 Earnings
